Multifaceted transcriptional reprogramming supports oxaliplatin chemoresistance in colorectal cancer cells.

Oxaliplatin resistance remains a critical barrier to effective colorectal cancer treatment. The molecular mechanisms underlying this resistance are not fully understood, highlighting the need to define the transcriptional alterations that contribute…

Preview only. Read the full abstract at the source